ROR1 ADC: AxcynDOTTM Dual Payload Platform
11:30 am - Tuesday 9th June 2026
- Outlining a dual-payload ADC platform for next-generation therapeutics
- Discovering anti-ROR1 ADC candidates
- Sharing a preclinical evaluation supporting enhanced anti-tumor activity and overcoming resistance
